Skip to main content
. 2021 Sep 6;11:17733. doi: 10.1038/s41598-021-97148-z

Figure 5.

Figure 5

PS83 and PS106 reduced the rate of paralysis in C. elegans strain expressing human beta-amyloid. (ae) Rate of paralysis curve of C. elegans Alzheimer’s model (GMC101) expressing full-length human beta-amyloid upon treatment with (a, d) 5 µM PS83, (b, e) 25 µM PS106, or (c) 100 mM metformin control. In (d, e), worms were reared on E. coli expressing cdc-25.1(RNAi)/vector(RNAi) or cdc-25.1(RNAi)/pink-1(RNAi). At least three biological replicates with ~ 180 worms/replicate were analyzed. p-values were determined from Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001. Black stars indicate significance compared to DMSO control. Red stars in (d, e) indicate statistical significance between PS compound on vector versus pink-1(RNAi)-reared animals.